Whittie J. An exact diary of the late expedition of His Illustrious Highness the Prince of Orange. 1689.

Brown JJ, Baloh RW. Persistent mal de debarquement syndrome: a motion-induced subjective disorder of balance. Am J Otolaryngol. 1987;8(4):219–22.

CAS  PubMed  Article  Google Scholar 

Cha YH, Cui YY, Baloh RW. Comprehensive Clinical Profile of Mal De Debarquement Syndrome. Front Neurol. 2018;9:261.

PubMed  PubMed Central  Article  Google Scholar 

•• Cha YH, Baloh RW, Cho C, Magnusson M, Song JJ, Strupp M, et al. Mal de debarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Barany Society. J Vestib Res. 2020;30(5):285–93. These are internationally endorsed diagnostic criteria for MdDS that supersede previous criteria.

PubMed  PubMed Central  Article  Google Scholar 

Brandt T, Dieterich M. The dizzy patient: don’t forget disorders of the central vestibular system. Nat Rev Neurol. 2017;13(6):352–62.

PubMed  Article  Google Scholar 

Kahane P, Hoffmann D, Minotti L, Berthoz A. Reappraisal of the human vestibular cortex by cortical electrical stimulation study. Ann Neurol. 2003;54(5):615–24.

PubMed  Article  Google Scholar 

Cha YH, Chakrapani S, Craig A, Baloh RW. Metabolic and functional connectivity changes in mal de debarquement syndrome. PLoS ONE. 2012;7(11): e49560.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Macke A, LePorte A, Clark BC. Social, societal, and economic burden of mal de debarquement syndrome. J Neurol. 2012;259(7):1326–30.

PubMed  Article  Google Scholar 

Arroll MA, Attree EA, Cha YH, Dancey CP. The relationship between symptom severity, stigma, illness intrusiveness and depression in Mal de Debarquement Syndrome. J Health Psychol. 2016;21(7):1339–50.

PubMed  Article  Google Scholar 

Canceri JM, Brown R, Watson SR, Browne CJ. Examination of current treatments and symptom management strategies used by patients with Mal De Debarquement syndrome. Front Neurol. 2018;9:943.

PubMed  PubMed Central  Article  Google Scholar 

•• Beh SC, Chiang HS, Sanderson C. The interconnections of Mal de Debarquement syndrome and vestibular migraine. Laryngoscope. 2021;131(5):E1653–61. This study provides a deep dive into the symptoms and modulators of symptoms experienced by patients with MdDS and nmPOV (our term) particularly as they relate to migraine.

CAS  PubMed  Article  Google Scholar 

Dai M, Cohen B, Smouha E, Cho C. Readaptation of the vestibulo-ocular reflex relieves the mal de debarquement syndrome. Front Neurol. 2014;5:124.

PubMed  PubMed Central  Article  Google Scholar 

Cha YH, Chakrapani S. Voxel based morphometry alterations in Mal de Debarquement Syndrome. PLoS ONE. 2015;10(8):e0135021.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Cha YH, Brodsky J, Ishiyama G, Sabatti C, Baloh RW. Clinical features and associated syndromes of mal de debarquement. J Neurol. 2008;255(7):1038–44.

PubMed  PubMed Central  Article  Google Scholar 

Cha YH, Cui Y. Rocking dizziness and headache: a two-way street. Cephalalgia. 2013;33(14):1160–9.

PubMed  PubMed Central  Article  Google Scholar 

• Riley J, Gleghorn D, Doudican BC, Cha YH. Psychological assessment of individuals with Mal de Debarquement Syndrome. J Neurol. Online 2021, Sept 21. This study describes the factors that are related to disability and duration of illness of MdDS including formal metrics on personality, depression, anxiety, empathy, and positive/negative valence.

Mucci V, Canceri JM, Brown R, Dai M, Yakushin SB, Watson S, et al. Mal de Debarquement Syndrome: a retrospective online questionnaire on the influences of gonadal hormones in relation to onset and symptom fluctuation. Front Neurol. 2018;9:362.

PubMed  PubMed Central  Article  Google Scholar 

Solstad T, Boccara CN, Kropff E, Moser MB, Moser EI. Representation of geometric borders in the entorhinal cortex. Science. 2008;322(5909):1865–8.

CAS  PubMed  Article  Google Scholar 

Goldsmith L, Moncrieff J. The psychoactive effects of antidepressants and their association with suicidality. Curr Drug Saf. 2011;6(2):115–21.

PubMed  Article  Google Scholar 

Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, et al. Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J. 2018;54(2):101–12.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Roseboom PH, Kalin NH. Neuropharmacology of venlafaxine. Depress Anxiety. 2000;12(Suppl 1):20–9.

PubMed  Article  Google Scholar 

Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167–72.

PubMed  Article  Google Scholar 

Arnold M. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.

Ghavami Y, Haidar YM, Ziai KN, Moshtaghi O, Bhatt J, Lin HW, et al. Management of mal de debarquement syndrome as vestibular migraines. Laryngoscope. 2017;127(7):1670–5.

PubMed  Article  Google Scholar 

Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32(6):300–4.

CAS  PubMed  Article  Google Scholar 

Wackym PA, Popper P, Abelson LA, Ward PH, Micevych PE. Molecular biology of the vestibular system. Acta Otolaryngol Suppl. 1991;481:141–9.

CAS  PubMed  Article  Google Scholar 

Tanaka M, Takeda N, Senba E, Tohyama M, Kubo T, Matsunaga T. Localization, origin and fine structure of calcitonin gene-related peptide-containing fibers in the vestibular end-organs of the rat. Brain Res. 1989;504(1):31–5.

CAS  PubMed  Article  Google Scholar 

Mason RT, Peterfreund RA, Sawchenko PE, Corrigan AZ, Rivier JE, Vale WW. Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells. Nature. 1984;308(5960):653–5.

CAS  PubMed  Article  Google Scholar 

Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett. 1985;62(1):131–6.

CAS  PubMed  Article  Google Scholar 

Mucci V, Jacquemyn Y, Van Ombergen A, Van de Heyning PH, Browne CJ. A new theory on GABA and calcitonin gene-related peptide involvement in Mal de Debarquement Syndrome predisposition factors and pathophysiology. Med Hypotheses. 2018;120:128–34.

CAS  PubMed  Article  Google Scholar 

Chiang CC, Schwedt TJ. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants. Prog Brain Res. 2020;255:143–70.

PubMed  Article  Google Scholar 

Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltran E, et al. Blocking CGRP in migraine patients - a review of pros and cons. J Headache Pain. 2017;18(1):96.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Dodick DW, Tepper SJ, Ailani J, Pannacciulli N, Navetta MS, Loop B, et al. Risk of hypertension in erenumab-treated patients with migraine: analyses of clinical trial and postmarketing data. Headache. 2021;61(9):1411–20.

PubMed  PubMed Central  Article  Google Scholar 

Dai M, Raphan T, Cohen B. Adaptation of the angular vestibulo-ocular reflex to head movements in rotating frames of reference. Exp Brain Res. 2009;195(4):553–67.

PubMed  Article  Google Scholar 

Yakushin S, Maruta J, Cho C. Habituation of velocity storage provides effective treatment for mal de debarquement syndrome (MdDS). Assoc Res Otolaryngol. 2018;9:20222022.

Dai M, Cohen B, Cho C, Shin S, Yakushin SB. Treatment of the Mal de Debarquement Syndrome: a 1-year follow-up. Front Neurol. 2017;8:175.

PubMed  PubMed Central  Article  Google Scholar 

Mucci V, Perkisas T, Jillings SD, Van Rompaey V, Van Ombergen A, Fransen E, et al. Sham-Controlled Study of Optokinetic Stimuli as Treatment for Mal de Debarquement Syndrome. Front Neurol. 2018;9:887.

PubMed  PubMed Central  Article  Google Scholar 

Yakushin SB, Zink R, Clark BC, Liu C. Readaptation treatment of Mal de Debarquement syndrome with a virtual reality app: a pilot study. front neurol. 2020;11:814.

Hoppes CW, Vernon M, Morrell RL, Whitney SL. Treatment of Mal de Debarquement Syndrome in a Computer-Assisted Rehabilitation Environment. Mil Med. 2021;20.

Cha YH, Cui Y, Baloh RW. Repetitive transcranial magnetic stimulation for mal de debarquement syndrome. Otol Neurotol. 2013;34(1):175–9.

PubMed  PubMed Central  Article  Google Scholar 

Cha YH, Deblieck C, Wu AD. Double-blind sham-controlled crossover trial of repetitive transcranial magnetic stimulation for Mal de Debarquement Syndrome. Otol Neurotol. 2016;37(6):805–12.

PubMed  PubMed Central  Article  Google Scholar 

Cha YH, Gleghorn D, Doudican B. Occipital and cerebellar theta burst stimulation for Mal De Debarquement Syndrome. Otol Neurotol. 2019;40(9):e928–37.

PubMed  PubMed Central  Article  Google Scholar 

Cha YH, Gleghorn D, Doudican BC. Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de debarquement syndrome. PLoS ONE. 2022;17(2):e0263558.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cha YH, Riley J, Gleghorn D, Doudican B. Remotely monitored home-based neuromodulation with transcranial alternating current stimulation (tACS) for Mal de Debarquement Syndrome. Front Neurol. 2021;12:755645.

PubMed  PubMed Central  Article